Colossus Minerals Inc

(COLUF)

By |

Profile

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Contact Information

Website: www.atreca.com
Email: greghoyuen@colossusminerals.com
Main Phone: +1 650 595-2595
Address: 450 East Jamie Court
Address 2: Suite 5600
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: OTO
CEO: John A. Orwin
Employees: 118
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Contact Information

Website: www.atreca.com
Email: greghoyuen@colossusminerals.com
Main Phone: +1 650 595-2595
Address: 450 East Jamie Court
Address 2: Suite 5600
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: OTO
CEO: John A. Orwin
Employees: 118
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.0031 $ 0. (0.00%)
Last Price 0.0031 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.0031
Last Trade Volume 7 52 Wk Hi 0.01 52 Wk Low 0.01
Market Cap 111,691 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 36,029,407.00 EPS (TTM) -2.24 PE Ratio N/A Exchange OTCPK